Gov. Greg Abbott (R) announced a May 4 special election to serve the remainder of former Sen. John Whitmire’s (D) term.
Also in Texas, the Pharmaceutical Initiative (TPI) Board held a meeting on February 9.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Health (DOH) contracted with Myers and Stauffer to conduct a pharmacy cost of dispensing survey to evaluate the cost of dispensing prescription medications in the state. The DOH scheduled a webinar on February 9 at 10:30 am AKST to discuss dispensing cost survey objectives and solicit feedback on the survey tool. If you are interested in participating, contact Matt Hill.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
This week, NACDS submitted a letter of support to the Senate Committee on Health and Human Services for SB 1085, authorizing pharmacists to test and initiate treatment for conditions such as influenza, COVID, strep and other respiratory illnesses and to delegate the administrative and technical tasks of performing a test to a trained member of the pharmacy staff who is under the supervision of the pharmacist. It also prohibits a health insurer from denying reimbursement for any test, screening or treatment that is within the scope of the pharmacist’s license and would be covered, if otherwise performed by a physician, nurse practitioner or physician assistant.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
AB 82, legislation establishing an age limit on select dietary supplements for weight loss or over-the-counter diet pills with penalties for violation, passed the Assembly. The bill also requires the Department of Public Health to develop a notice that retail establishments must post.
Also in California, NACDS submitted a letter of support to Gov. Gavin Newsom (D) urging enactment of California SB 339, which broadens existing pharmacist authority to provide HIV prevention services and secures payment for the provision of pharmacy-provided HIV prevention services.
Also in California, the Board of Pharmacy posted its agenda and meeting materials for the full board meeting on February 8. The board will discuss and potentially act on proposed rules related to the pharmacist-in-charge designation, the opioid antagonist protocol and continuing education.
Finally in California, the Department of Health Care Services posted the following alerts and monthly bulletin on the Medi-Cal Rx Web Portal.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Commission of Pharmacy held its regular monthly meeting on January 31. Several licenses and disciplinary actions were considered; no policy decisions were on the agenda.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
On January 31, the Board of Pharmacy held its regular monthly meeting. The Board continued the following unfinished business from last year:
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
On January 31, the House Committee on Health and Homelessness recommended that HB 2553, legislation relate to expansion of pharmacist immunization authority, be passed with amendments by a vote of 7-1. The bill would also expand the authority of pharmacy interns and technicians under the supervision of a pharmacist to administer vaccinations.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Healthcare and Family Services (HFS) submitted a State Plan Amendment (SPA) to the Centers for Medicare & Medicaid Services (CMS) to change the methodology by which HFS will reimburse providers for costs associated with the administration of the COVID-19 vaccine.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The next PBM Monitoring Advisory Council meeting, on which NACDS has a designated seat in statute, will be meeting on February 7 at 10:30 am at the Department of Insurance offices in Baton Rouge.
Also in Louisiana, the Prescription Monitoring Program (PMP) Advisory Council, on which NACDS has a designated seat in statute, will be meeting February 7 at 1:30 pm at the Board of Pharmacy office.
Finally in Louisiana, the Medicaid Fee for Service (FFS) Pharmacy Program and Managed Care Organizations (MCOs) updated the reimbursement methodology for clotting factor products effective on February 1.
For more information, contact NACDS’ Mary Staples at 817-442-1155.